|
UBN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.22150000114729E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8362199999955E-05 |
| Normal-vs-Stage2 |
3.227800E-02 |
| Normal-vs-Stage3 |
7.143800E-01 |
| Normal-vs-Stage4 |
2.477600E-01 |
| Stage1-vs-Stage2 |
5.087800E-01 |
| Stage1-vs-Stage3 |
7.282000E-03 |
| Stage1-vs-Stage4 |
7.574000E-02 |
| Stage2-vs-Stage3 |
5.913600E-02 |
| Stage2-vs-Stage4 |
1.266150E-01 |
| Stage3-vs-Stage4 |
6.432800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.48210000050497E-07 |
| Normal-vs-AfricanAmerican |
2.536800E-03 |
| Normal-vs-Asian |
4.663000E-01 |
| Caucasian-vs-AfricanAmerican |
6.143600E-01 |
| Caucasian-vs-Asian |
5.597200E-01 |
| AfricanAmerican-vs-Asian |
6.660000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.96010000242231E-08 |
| Normal-vs-Female |
3.790200E-04 |
| Male-vs-Female |
7.498600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.786300E-02 |
| Normal-vs-Extreme_Weight |
1.317500E-03 |
| Normal-vs-Obese |
2.240300E-04 |
| Normal-vs-Extreme_Obese |
2.696800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.762800E-01 |
| Normal_Weight-vs-Obese |
2.344800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.243200E-01 |
| Extreme_Weight-vs-Obese |
6.359600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.606200E-01 |
| Obese-vs-Extreme_Obese |
5.544400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.831800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.06040000008778E-08 |
| Normal-vs-Age(61-80Yrs) |
3.040300E-04 |
| Normal-vs-Age(81-100Yrs) |
4.111600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.117400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.897600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.144400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.719600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.103400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.734800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.79889436680014E-12 |
| Normal-VS-Type2 PRCC |
1.032590E-01 |
| Normal-VS-KIRP CIMP |
8.816600E-01 |
| Normal-VS-Unclassified PRCC |
1.028230E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.22044604925031E-16 |
| Type1 PRCC-VS-KIRP CIMP |
9.90410000000219E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.854620E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.634400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.641380E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.076100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.177240E-01 |
| Normal-vs-N1 |
2.352400E-01 |
| Normal-vs-N2 |
3.945400E-01 |
| N0-vs-N1 |
9.631400E-01 |
| N0-vs-N2 |
8.993800E-01 |
| N1-vs-N2 |
9.099200E-01 |
|
|
